Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Canis familiaris allergen 2 (Can f 2) is a major allergen produced by the domestic dog, belonging to the lipocalin family of proteins (UniProt: P15413). It is primarily secreted in dog saliva and becomes airborne when attached to dander and hair (WHO/IUIS Allergen Nomenclature). Biologically, Can f 2 functions as a transport protein for small hydrophobic ligands, such as pheromones, which is a characteristic trait of the lipocalin superfamily (PubMed: 15585361). In humans, exposure to Can f 2 can trigger an IgE-mediated hypersensitivity reaction in sensitized individuals, contributing significantly to symptoms of allergic rhinitis and bronchial asthma (PubMed: 10474032). As a therapeutic target, it is the focus of allergen-specific immunotherapy (ASIT), where controlled exposure to the protein is used to induce immunological tolerance and reduce allergic symptoms (PubMed: 22405131). Understanding its structure is crucial due to its high degree of cross-reactivity with other mammalian lipocalins, which can complicate clinical diagnosis and treatment (PubMed: 15585361).
Allergen-specific immunotherapy (ASIT) involves the administration of increasing doses of the allergen to induce immunological tolerance, characterized by a shift from a Th2 to a Th1/Treg immune response and the production of IgG4 blocking antibodies (PubMed: 22405131).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Canis familiaris allergen 2 (Can f 2) (Can f 2).